Trial intelligence / Profile preview

Diquafosol tetrasodium in Dry Eye Disease

NCT00600288Phase 3Completed

Sponsor
Merck & Co.
Start
Jan 2008
Primary completion
May 2008
Modality
Small Molecules
01

Overview

A Phase 3 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Jan 2008; status: completed.

02

Drugs

diquafosol
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT00600288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00600288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call